Biotechnology News

October 23, 2012

--(BUSINESS WIRE)--Kef Kasdin, CEO, Proterro, Inc., developer of fermentation-ready sugar for economical/scalable production of biofuels + biobased chemicals, to discuss feedstock economics at Adv. Biofuels Markets 2012

October 23, 2012

SAN DIEGO--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from the PURSUE Phase III study of 1,390 women, aged 35-42 years, for corifollitropin alfa, the company's investigational...

October 23, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and LifeMap Sciences, Inc. announce the launch of MalaCards, a new database of human diseases that is based on their leading GeneCards® platform. MalaCards (...

October 23, 2012

HOUSTON--(BUSINESS WIRE)--Biomedical diagnostics company Aggredyne, Inc., adds experienced directors with success in building high-growth enterprises. Aggredyne is defining a new standard for platelet function testing.

October 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News: Cellectis bioresearch, the specialist in genome customization and commercial subsidiary of Cellectis (Paris:ALCLS) (Alternext: ALCLS), announces that it has been awarded a second contract to...

October 23, 2012

MILAN--(BUSINESS WIRE)--Dompé, one of Italy’s leading biopharmaceutical companies, today announced the enrolment of the first patient into a Phase III trial on Reparixin, the compound that has shown to improve the efficacy of transplantation of...

October 23, 2012

NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that the Company...

October 23, 2012

CINCINNATI--(BUSINESS WIRE)--505(b)(2) drug development process expert Ken Phelps, Camargo Pharmaceutical Services president and CEO, will be a keynote speaker at the 4th Chinese Pharmaceutical Industry Globalization Workshop.

October 23, 2012

INDIANAPOLIS--(BUSINESS WIRE)--Redbird Medical, an Indiana-based contract manufacturer for the life science and health care industries, today announces the launch of its robust, customizable services.

October 23, 2012

GEORGETOWN, Texas--(BUSINESS WIRE)--DiFusion Technologies, Inc. and Evonik Degussa Corporation are working together to develop a product called CleanFUZE™, a new medical polymer that prevents infection while promoting bone growth.

October 23, 2012

MT. OLIVE, N.J.--(BUSINESS WIRE)--The Pinsonault Managed Markets Summit is pleased to announce a celebrated lineup of keynote speakers for the spring 2013 conference taking place February 26-28 at the InterContinental Miami. The three-day...

October 23, 2012

LOUVAIN-LA-NEUVE, Belgium--(BUSINESS WIRE)--Latest advances in cancer-fighting proton therapy technology from IBA to be featured at ASTRO in Boston.

October 23, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Patient-centric pharmaceutical companies are more likely to have larger medical information budgets and staffs, according to a recent study by Cutting Edge Information.

October 23, 2012

CAMBRIDGE, Mass. & LONDON--(BUSINESS WIRE)--AstraZeneca and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today an agreement to co-develop and co-commercialize Ironwood’s linaclotide in China. Linaclotide is the first and only...

October 23, 2012

NORCROSS, Ga. & ANKARA, Turkey--(BUSINESS WIRE)--Guided Therapeutics Selects Distributor for LuViva® Advanced Cervical Scan in Turkey and Select Territories

October 23, 2012

MAYNARD, Mass.--(BUSINESS WIRE)--Allegro Diagnostics presented positive results on the diagnostic accuracy of the BronchoGen test at CHEST 2012. Combined with bronchoscopy, the sensitivity of detecting lung cancer is 94 percent.

October 23, 2012

SAVANNAH, Ga.--(BUSINESS WIRE)--Health Discovery Corporation Issues Corporate Update

October 23, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that it has expanded its antibody-drug conjugate (ADC) collaboration with Abbott (NYSE:ABT). Under the expanded deal, Abbott will pay an upfront fee of $25...

October 23, 2012

SAN FRANCISCO & PARIS--(BUSINESS WIRE)--SpineGuard has disclosed to START-UP Magazine that the Company is considering new applications beyond spine surgery for its breakthrough PediGuard® platform. The Company is miniaturizing PediGuard’s...

October 23, 2012

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG) (the “Company”), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using...

October 23, 2012

BASKING RIDGE, N.J.--(BUSINESS WIRE)--Ipsen today announced its commitment to award up to $300,000 in grants to the Dystonia Medical Research Foundation's 2013 Clinical Fellowship Training Program.

October 23, 2012

SANTA ROSA, Calif.--(BUSINESS WIRE)--Direct Flow Medical, Inc., a transcatheter heart valve innovator focused on improving patient outcomes, announced that its DISCOVER CE Mark Trial met its primary mortality endpoint. The study also demonstrated...

October 23, 2012

TORONTO--(BUSINESS WIRE)--MRG's extension of its Marketrack product now allows clients to track the performance of their brands by stock keeping unit (SKU) in US hospitals, month over month.

October 23, 2012

SAN DIEGO--(BUSINESS WIRE)--Cytori announces that an independent investigator-sponsored/funded trial using Cytori's cell therapy to treat scleroderma has been approved to begin in Marseille, France.

October 23, 2012

BOUDRY, Switzerland--(BUSINESS WIRE)--Phase III study of pomalidomide combination in myeloma achieves significant improvement in progression-free survival and overall survival

October 23, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ: CGEN) today announced that the Company will host a conference call at 10:00 AM EDT on Tuesday, October 30, 2012 to review third quarter 2012 results. The quarterly results will be released...

October 23, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (“Elan”) (NYSE: ELN) announced today the expiration and final results of the cash tender offer and consent solicitation (the “Tender Offer and Consent Solicitation”), commenced on September 24, 2012...

October 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem appoints Joanna Horobin, M.B., Ch.B., a veteran drug developer, as its CMO.

October 23, 2012

MELVILLE, N.Y.--(BUSINESS WIRE)--Bovie Medical Corporation (the “Company”) (NYSE Amex: BVX), a manufacturer and marketer of electrosurgical products, today announced that Jeff Rencher, Vice President of Sales and Marketing of Surgical Products,...

October 23, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will host a conference call and live webcast to report its third quarter 2012 financial results on Tuesday, October 30 at 8:30 a.m. ET. To...

October 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today announced that financial results for the company’s third quarter ended September 30, 2012 will be released before the market opens on Tuesday, October 30, 2012. The AVEO...

October 23, 2012

BOSTON--(BUSINESS WIRE)--Highland Instruments, Inc., (“Highland”) today announced IRB approval to initiate a clinical evaluation of Highland’s ElectroSonic Stimulation (“ESStim™”) technology for the treatment of Parkinson’s Disease (“PD”)1. The...

October 23, 2012

SAN DIEGO--(BUSINESS WIRE)--Drug Development Boot Camp

October 23, 2012

BELLEVUE, Wash. & MENLO PARK, Calif.--(BUSINESS WIRE)--Kona Medical has initiated a clinical study of its novel renal denervation therapy. Kona Surround Sound(TM) utilizes externally-delivered therapeutic ultrasound energy to treat...

October 23, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: BioGaia: (STO:BIOG) 1 January – 30 September 2012 - Net sales reached SEK 572.8 million (232.6). This figure includes licence revenue of SEK 356.0 million from Nestlé that is regarded as non-recurring...

October 22, 2012

CENTER VALLEY, Pa.--(BUSINESS WIRE)--On October 24, 2012, Aesculap Implant Systems will debut the ArcadiusXP L Stand alone Interbody Device for ALIF procedures during the North American Spine Society (NASS) Annual Meeting being held in Dallas,...

October 22, 2012

KANSAS CITY, Mo.--(BUSINESS WIRE)--Taking place November 15, 2012, at the Ritz Charles Convention Center in Overland Park, Kansas, the BioResearch Central Summit is designed to bring together leaders in non-clinical, pre-clinical and clinical...

October 22, 2012

LAKE FOREST, Calif.--(BUSINESS WIRE)--Cryoport, Inc. (OTCBB: CYRX) announced that Jerrell Shelton was elected to its Board of Directors today. Mr. Shelton has served on many public and private boards and currently sits on the Smithsonian...

October 22, 2012

NEW YORK & SAO PAULO--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX), an international pharmaceutical company, and moksha8, a leader in the commercialization of CNS medicines in Latin America, today announced that they have entered...

October 22, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR) announced today it has promoted Lode Debrabandere, Ph.D. to the role of Chief Operating Officer (COO) reporting directly to Chief Executive Officer, C. Randal Mills, Ph.D....

October 22, 2012

REHOVOTH, Israel--(BUSINESS WIRE)--Pharma Two B Ltd., a privately held company focused on developing Fixed-Dose-Combinations (FDCs) of two or more drugs with complementary and synergistic effects, announced that it has completed its second round...

October 22, 2012

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS has announced positive data from the APPOSITION III trial at TCT in Miami. The STENTYS Self-Apposing stent is being assessed in Europe in patients suffering from heart attack (STEMI).

October 22, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Sequella Inc., a clinical-stage pharmaceutical company developing novel antibiotics to treat life-threatening infectious diseases, licensed its B-SMART™ technology to Laboratory Corporation of America® Holdings (...

October 22, 2012

HOUSTON--(BUSINESS WIRE)--SpinalCyte, LLC, a spinal technology company focused on autologous regrowth of the spinal disc nucleus using human dermal fibroblasts (HDFs), today announced the addition of Nicholas Theodore, M.D. to its Clinical...

October 22, 2012

GAITHERSBURG, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, announced today that preclinical data related to its lead...

October 22, 2012

BERWYN, Pa.--(BUSINESS WIRE)--After oral treatment, Posiphen totally restored cognitive function in Alzheimer mice. No plaque was detected and the levels of APP/Ab42 and Tau/phospho-Tau returned to normal.

October 22, 2012

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT: CVM) announced today that an interim review of the safety data from its open label, randomized, controlled, pivotal Phase III study of Multikine (Leukocyte Interleukin, Injection)...

October 22, 2012

CAESAREA, Israel--(BUSINESS WIRE)--Mazor's surgical robotics Renaissance system enters the Japanese market through its distributor, Adachi Medical Instruments

October 22, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) today announced that it has received $300,000 through the issuance of unsecured convertible notes to two members of...